Probal Banerjee | Biological Network | Best Researcher Award

Dr. Probal Banerjee | Biological Network | Best Researcher Award

The College of Staten Island (City University of New York) | United States

Dr. Probal Banerjee is a distinguished biochemist and neuroscientist whose academic and research career spans over four decades of excellence in bioorganic chemistry, molecular neuroscience, and cancer research. He earned his B.Sc. in Chemistry (Hons) and M.Sc. in Organic Chemistry from Jadavpur University, Calcutta, followed by a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore in 1984. He completed postdoctoral research at the University of Notre Dame in Biochemistry and Enzymology and at the University of Chicago in Molecular Neuroscience. Currently a Professor of Chemistry and Coordinator at the Center for Developmental Neuroscience, College of Staten Island, CUNY, Dr. Banerjee has made pioneering contributions to understanding neurodevelopmental signaling and immune-modulating cancer therapies. His numerous honors include the Children’s Research Foundation Grant (1989), Brain Research Foundation Award, and two Dolphin Awards for Academic Excellence and Teaching. A sought-after speaker, he has delivered invited lectures at leading institutions worldwide on topics ranging from serotonin signaling in brain development to multi-target cancer therapeutics. Dr. Banerjee is also an inventor with several patents on curcumin-based anticancer agents and therapeutic approaches for Fragile X Syndrome. His expertise is widely recognized through his service on multiple NIH grant review committees, reflecting his enduring impact on neuroscience, pharmacology, and translational cancer research.

Profiles: Orcid 

Featured Publications

"Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions", Shubhasmita Mohapatra; Adrian Guerrero; Neha Rahman; Khondoker Takia Zaman; Jing Wu; Callistus Onyeagba; Chanyue Hu; Matteo Pellegrini; Jayaram Vankudoth; Seiya Kitamura et al., Cells, 2025.

"One-Pot Synthesis of Phenylboronic Acid-Based Microgels for Tunable Gate of Glucose-Responsive Insulin Release at Physiological pH", Prashun G. Roy; Jiangtao Zhang; Koushik Bhattacharya; Probal Banerjee; Jing Shen; Shuiqin Zhou, Molecules, 2025.

"Biocompatible Anisole-Nonlinear PEG Core–Shell Nanogels for High Loading Capacity, Excellent Stability, and Controlled Release of Curcumin", Jing Shen; Jiangtao Zhang; Weitai Wu; Probal Banerjee; Shuiqin Zhou, Gels 2023.

"The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus", Sreyashi Samaddar; Sudarshana Purkayastha; Souleymane Diallo; Subramanyam J. Tantry; Ryan Schroder; Pranavan Chanthrakumar; Michael J. Flory; Probal Banerjee, International Journal of Molecular Sciences 2022.

"Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells", Sumit Mukherjee; Angela Fried; Rahman Hussaini; Richard White; Juliet Baidoo; Sri Yalamanchi; Probal Banerjee, Journal of Experimental & Clinical Cancer Research, 2018.

June Round | Biological Networks | Best Researcher Award 

Dr. June Round | Biological Networks | Best Researcher Award 

University of Utah | United States

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. June Round’s academic journey reflects a foundation of dedication and scholarly excellence. Beginning with a B.S. in Biology (Cum Laude) at California Lutheran University, she distinguished herself early through departmental honors and multiple scholarships. Her passion for molecular biology led to an M.S. from the University of the Pacific, followed by a D.Phil. in Microbiology, Immunology, and Molecular Genetics at UCLA, supported by highly competitive fellowships. Her formative postdoctoral training at the California Institute of Technology under Sarkis K. Mazmanian provided a strong platform to explore the intricate interplay between microbiota and host immunity, setting the stage for her pioneering career.

Professional Endeavors

Currently serving as a Professor at the University of Utah, Dr. Round has held numerous leadership roles including Director of the Mountain West Microbiota Alliance (MoWMA) and Co-Director of the Microbiota and GI Immunology Consortia (MAGIC). She has chaired multiple search committees, overseen postdoctoral studies, and contributed extensively to university-level, college-level, and departmental governance. Her sustained involvement in NIH study sections, national symposia, and scientific advisory boards underscores her standing as a leader in immunology and microbial pathogenesis.

Contributions and Research Focus

Dr. Round’s research focuses on microbiota–immune system interactions, particularly their role in regulating immune tolerance and driving inflammatory diseases. Her laboratory has produced high-impact work elucidating mechanisms by which commensal microbes shape host immunity, contributing to transformative understanding in immunology, microbiology, and gastrointestinal health. Her investigations into toll-like receptors, dysbiosis, and immune regulation have provided new frameworks for therapeutic exploration in autoimmune and inflammatory disorders.

Impact and Influence

The significance of Dr. Round’s research is reflected in her numerous prestigious awards, including the NIH Innovator Award, Packard Fellowship, Pew Scholar Award, Burroughs Wellcome Investigator in Pathogenesis, and the W.M. Keck Research Award. These honors not only recognize her innovative contributions but also demonstrate her influence in shaping the field. She has trained and mentored a generation of young scientists, many of whom now serve as professors, researchers, and clinicians in leading institutions worldwide—an enduring testament to her academic leadership.

Academic Citations and Recognition

Dr. Round’s scholarship has been widely published in top-tier journals including Cell, Nature Reviews Immunology, Science Immunology, and Annual Review of Microbiology. Her reviews and original research articles are highly cited, frequently shaping discourse in immunology and microbiome research. Her contributions extend beyond publications through book chapters and invited conference proceedings, amplifying her thought leadership in the global scientific community.

Legacy and Future Contributions

Dr. Round’s legacy lies in bridging microbiology and immunology, redefining the microbiota’s role in human health and disease. Through her pioneering studies, administrative leadership, and mentorship, she has cultivated a scientific ecosystem that will continue to grow. Moving forward, her leadership in major microbiome initiatives and consortia is poised to advance translational breakthroughs, from novel therapeutics for autoimmune disease to deeper insights into the human–microbe interface.

Conclusion

Dr. June Round’s career reflects the hallmarks of an exceptional researcher: rigorous scholarship, innovative vision, academic leadership, and transformative mentorship. Her pioneering contributions to microbiome and immune system research have reshaped fundamental scientific understanding while fostering future leaders in biomedical science. With her remarkable impact, both in the laboratory and across academic institutions, Dr. Round stands as an exemplary candidate for the Best Researcher Award.

Notable Publications

"Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development

  • Author: JH Hill, R Bell, L Barrios, H Baird, K Ost, M Greenewood, JK Monts
  • Journal: Science
  • Year: 2025

"The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients

  • Author: DA Byrd, V Damerell, MF Gomez Morales, SR Hogue, T Lin, J Ose
  • Journal: International Journal of Cancer
  • Year: 2025

"A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy

  • Author: WW Tang, B Battistone, KM Bauer, AM Weis, C Barba, MZH Fadlullah
  • Journal: Cell reports
  • Year: 2025

"Primary tumor microbiomes predict distant metastasis of colorectal cancer

  • Author: B Parajuli, V Midya, R Kiddle, N De Jager, S Eggers, D Spakowicz
  • Journal: Cell reports
  • Year: 2025

"Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals

  • Author: TR Chiaro, M Greenewood, KM Bauer, KS Ost, E Stephen-Victor
  • Journal: bioRxiv
  • Year: 2025